17 Oct 2013, BioSpectrum Bureau , BioSpectrum
Singapore: Sartorius Stedim Biotech (SSB), an international pharma and biotech supplier, and BD Diagnostics, medical technology company, have collaborated to develop, manufacture and market various ready-to-use, prefilled media products for microbiological applications in pharmaceutical, biotech and research laboratories.
"Through our agreement with BD, we have created an excellent collaboration. BD is known worldwide for its expertise in manufacturing and filling of microbial media. BD's expertise combined with Sartorius Stedim Biotech's know-how in polymeric technologies and applications will help us further extend our expert capabilities in the field of microbiological monitoring," said Mr. Dominique Baly, member of the Sartorius Group Executive Committee.
"The products we plan to develop under our agreement with Sartorius Stedim Biotech will enhance laboratory efficiencies for our pharmaceutical, biotech and research customers with these unique product offerings," said Mr. Bob Ferguson, Vice President and General Manager, BD Diagnostics - Diagnostic Systems, Industrial Microbiology. "By combining Sartorius Stedim Biotech's bioprocessing and filtration expertise with BD's microbiological media capabilities, customers will benefit from improved lab productivity and standardization of sample processing."